Study on compliance with breakthrough cancer pain guidelines by medical oncologists in Spain.

Authors

null

Rafael Lopez

Hospital Clinico Universitario de Santiago de Compostela, Santiago de Compostela, Spain

Rafael Lopez , Carlos Camps , Parham Khosravi-Shahi , Vicente Guillem , Alfredo Carrato , Jesus Garcia-Foncillas , Juan J. Cruz , Pedro Gascon , Antonio Anton , Eduardo Diaz-Rubio , Margarita Feyjoo , Enrique Aranda

Organizations

Hospital Clinico Universitario de Santiago de Compostela, Santiago de Compostela, Spain, Consorcio Hospital General Universitario de Valencia, Department of Medicine, Universitat de Valencia, Valencia, Spain, Hospital de Torrejón, Madrid, Spain, IVO, Valencia, Spain, Medical Oncology Department, Ramon y Cajal University Hospital, Madrid, Spain, Oncology Department and Translational Oncology Division, University Hospital Fundacion Jimenez Diaz, Madrid, Spain, Hospital Universitario de Salmanca, Salamanca, Spain, Fundacio Clinic, Barcelona, Spain, Hospital Universitario Miguel Servet, Zaragoza, Spain, Hospital Clínico San Carlos, Madrid, Spain, Hospital Sanitas La Moraleja, Madrid, Spain, Reina Sofía Hospital, University of Cordoba, Maimonides Institute of Biomedical Research, Spanish Cancer Network, Instituto de Salud Carlos III, Cordoba, Spain

Research Funding

Pharmaceutical/Biotech Company

Background: Breakthrough cancer pain (BTcP) has been shown to be a prevalent and poor prognostic factor for cancer patients, which remains undertreated and underdiagnosed. The Spanish Society for Medical Oncology (SEOM) developed a clinical practice guideline (CPG) for the treatment of cancer pain which specifically addressed the management of BTcP. Methods: With the objective of evaluate compliance with SEOM’ guideline, Fundación ECO designed a survey to identify awareness, perceptions, implementation and gaps, among Spanish medical oncologists. Results: A total of 83 oncologists with a median experience of 13 years responded. Although 87% of oncologists considered their clinical practice complied with SEOM recommendations, there were discrepancies between what oncologists agreed to do versus how they do in clinical practice, as shown in the table. Main barriers identified in our study were time pressure together with vague statements in some recommendations, and the need to regularly update to reflect the most recent knowledge on therapeutic management. Conclusions: Nonetheless, this nationwide survey reflects that oncologist’s clinical practice is increasingly guided by GPC, and thus, the evaluation process is necessary, both to gauge the true application of the GPC by the professionals and to evaluate their impact on health care.

AGREEMENT withADHERENCE to
99% SEOM CPG provides the most recent evidence-based care recommendations- 86.7% declare full compliance with SEOM CPG
- 7.2% consider CPG recommendations inappropriate
100% The prescription of specific medication for BTcPCore factors when prescribing analgesia for BTcP: fast onset, high potency and short duration of effect
- 97.6% recorded efficacy
- 91.6 % recorded adverse effects
99% Fentanyl as first-choice drug for BTcP treatment85.7%- 95% prescribed fentanyl as first-choice
100% The minimum information recommended to be gathered for the clinical historyImplementation in medical history:
- 73.5% number of episodes
- 66.3% pain intensity
- 45.8% duration of episodes
- 30.1% time to highest-intensity peak
- 75.9% possible triggers
- 73.5% relief strategies
- 86.7% etiopathogenic mechanisms

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2017 ASCO Annual Meeting

Session Type

Publication Only

Session Title

Publication Only: Health Services Research, Clinical Informatics, and Quality of Care

Track

Quality Care/Health Services Research

Sub Track

Safety and Quality of Care

Citation

J Clin Oncol 35, 2017 (suppl; abstr e18260)

DOI

10.1200/JCO.2017.35.15_suppl.e18260

Abstract #

e18260

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Quality Care Symposium

Prescribing comfort: Understanding pain medication prescribing patterns in cancer care.

First Author: Jennifer Fernandez

Abstract

2021 ASCO Annual Meeting

Analysis of opioid and adjunctive pain medication prescriptions in lung cancer patients.

First Author: Benjamin Aaron Bleiberg

First Author: Fumiko Chino

Abstract

2023 ASCO Annual Meeting

Quality of pain management in patients with cancer in the outpatient setting.

First Author: Biplov Adhikari